Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPB-01 vs Steroid Pulse in Refractory Autoimmune Encephalitis
NCT05177939Phase 3Unknown
- Sponsor
- Nihon Pharmaceutical
- Start
- Mar 2022
- Primary completion
- May 2024
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of NPB-01-ME in Autoimmune Encephalitis (AE), sponsored by Nihon Pharmaceutical. Status: unknown.
02
Drugs
NPB-01-ME
03
Conditions
Autoimmune Encephalitis (AE)
Beyond the preview
Go deeper on NCT05177939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05177939.